Roles of a prostaglandin E‐type receptor, EP3, in upregulation of matrix metalloproteinase‐9 and vascular endothelial growth factor during enhancement of tumor …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui… - Cancer …, 2009 - Wiley Online Library
Cyclooxygenase (COX)‐2 is known to correlate with poor cancer prognosis and to contribute
to tumor metastasis. However, the precise mechanism of this phenomenon remains …

Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui… - Cancer …, 2009 - europepmc.org
Cyclooxygenase (COX)-2 is known to correlate with poor cancer prognosis and to contribute
to tumor metastasis. However, the precise mechanism of this phenomenon remains …

Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui… - Cancer …, 2009 - pubmed.ncbi.nlm.nih.gov
Cyclooxygenase (COX)-2 is known to correlate with poor cancer prognosis and to contribute
to tumor metastasis. However, the precise mechanism of this phenomenon remains …

[引用][C] Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of …

H AMANO, Y ITO, T SUZUKI, S KATO, Y MATSUI… - Cancer …, 2009 - jglobal.jst.go.jp
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9
and vascular endothelial growth factor during enhancement of tumor metastasis | Article …

Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui… - Cancer …, 2009 - tus.elsevierpure.com
Abstract Cyclooxygenase (COX)-2 is known to correlate with poor cancer prognosis and to
contribute to tumor metastasis. However, the precise mechanism of this phenomenon …

[PDF][PDF] Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui, F Ogawa… - Cancer Sci, 2009 - academia.edu
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9
and vascular endothelial growth fac Page 1 Roles of a prostaglandin E-type receptor, EP3, in …

Roles of a prostaglandin E‐type receptor, EP3, in upregulation of matrix metalloproteinase‐9 and vascular endothelial growth factor during enhancement of tumor …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui, F Ogawa… - Cancer Science, 2009 - cir.nii.ac.jp
抄録< jats: p> Cyclooxygenase (COX)‐2 is known to correlate with poor cancer prognosis
and to contribute to tumor metastasis. However, the precise mechanism of this phenomenon …

[HTML][HTML] Roles of a prostaglandin E‐type receptor, EP3, in upregulation of matrix metalloproteinase‐9 and vascular endothelial growth factor during enhancement of …

H Amano, Y Ito, T Suzuki, S Kato, Y Matsui… - Cancer …, 2009 - ncbi.nlm.nih.gov
Abstract Cyclooxygenase (COX)‐2 is known to correlate with poor cancer prognosis and to
contribute to tumor metastasis. However, the precise mechanism of this phenomenon …

[引用][C] Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of …

A Hideki, ITO Yoshiya, S Tastunori, K Shintaro… - Cancer science, 2009 - cir.nii.ac.jp
Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and
vascular endothelial growth factor during enhancement of tumor metastasis | CiNii Research …

[引用][C] Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of …

H AMANO, Y ITO, T SUZUKI, S KATO, Y MATSUI… - Cancer science, 2009 - Blackwell